The study by Medeiros et al. [39] aimed to study patients on hemodialysis and determine the associations of sarcopenia with serum sclerostin concentrations, which is an osteoblast-inhibiting glycoprotein secreted mainly by osteocytes and regulated by hormonal changes and skeletal loading. Here, SOST is linked to sarcopenia.